Human-relevant preclinical models for drug development combining patient‑derived biology, advanced 3D bioprinting, and engineered tissue/organ-on-chip platforms. Scalable, fit-for-purpose systems for oncology and immune-mediated disease research that generate reproducible, translational data to improve decision-making.